Browse All

Current Filters

CLEAR FILTER x

TITLE

Title
    Author Last Name
      Session Name
        Topic
          Program Number
            Author Institution

              More Than “Other”: Exploring Representation of Minoritized Individuals in Headache Research

              Author:Cheng, Nan   Halker Singh, Rashmi   

              Session Name:P3: Headache: Health Equity, Disparities, and Global Research 1  

              Topic:Headache  

              Program Number:P3.003  

              Author Institution:

              Impact of Atogepant on Activity Limitation in Participants With Episodic Migraine and Chronic Migraine: Post Hoc Analyses of ADVANCE, ELEVATE, and PROGRESS

              Author:Lipton, Richard   Gandhi, Pranav   Halker Singh, Rashmi   Yuan, Hsiangkuo   Gantenbein, Andreas   Dabruzzo, Brett   Umashankar, Kandavadivu   Duan, Molly   Stokes, Jonathan   Buse, Dawn   

              Session Name:P9: Headache: Advances in CGRP Inhibitors and Migraine 2  

              Topic:Headache  

              Program Number:P9.004  

              Author Institution:Albert Einstein College of Medicine, Bronx, NY  AbbVie, North Chi, IL  Mayo Clinic, Scottsdale, AZ  Thomas Jefferson University Headache Center, Philadelphia, PA  ZURZACH Care, Bad Zurzach, Switzerland  AbbVie, Frederick, MD  AbbVie, Madison, NJ  AbbVie, Cambridge, MA  

              Network Meta-Analysis Comparing Efficacy and Safety Outcomes of Atogepant, Rimegepant, and Galcanezumab in Patients with Episodic Migraine After Including CHALLENGE-MIG Trial

              Author:Ailani, Jessica   Gandhi, Pranav   Lalla, Anjana   McAllister, Peter   Bilchik, Tanya   Nahas, Stephanie   Rowe, David   Piron, Cristiano   Kelton, Kari   Halker Singh, Rashmi   

              Session Name:P9: Headache: Advances in CGRP Inhibitors and Migraine 2  

              Topic:Headache  

              Program Number:P9.007  

              Author Institution:

              Economic Impact of Early Vs. Late Initiation of Atogepant for The Preventive Treatment of Migraine

              Author:Ailani, Jessica   Lalla, Anjana   Gandhi, Pranav   Carr, Karen   Dabruzzo, Brett   Halker Singh, Rashmi   Lipton, Richard   

              Session Name:P10: Headache: Advances in CGRP Inhibitors and Migraine 3  

              Topic:Headache  

              Program Number:P10.007  

              Author Institution:Medstar Georgetown Neurology, McLean, VA  AbbVie, San Diego, CA  AbbVie, Mettawa, IL  AbbVie, Frederick, MD  Mayo Clinic, Scottsdale, AZ  Albert Einstein College of Medicine, Bronx, NY  

              Impact of Atogepant on Daily Functioning in Patients with Episodic Migraine and Chronic Migraine: Activity Impairment in Migraine-Diary (AIM-D) Item-Level Analysis

              Author:Lipton, Richard B.   Gandhi, Pranav   Buse, Dawn C.   Halker Singh, Rashmi   Yuan, Hsiangkuo   Stokes, Jonathan   Umashankar, Kandavadivu   Dabruzzo, Brett   Duan, Molly   Gantenbein, Andreas R.   

              Session Name:P12: Headache: Advances in CGRP Inhibitors and Migraine 4  

              Topic:Headache  

              Program Number:P12.004  

              Author Institution: